drug approval

Drug approval is the official permission slip a government regulator issues that lets a drug be marketed and sold for a stated medical use. Before this stamp, a new medicine cannot legally be advertised or prescribed for that purpose, no matter how promising its science looks. It is the gate between the world of experiments and the world of pharmacies.

To grant approval, an agency such as the US FDA, the European Medicines Agency, or China's NMPA reviews a large dossier of evidence: the chemistry and manufacturing details, the laboratory and animal studies, and above all the human trial results. The central judgment is one of balance, weighing the demonstrated benefits against the known and possible harms for the intended patients, together with how reliably the drug can be made to a consistent quality.

An approval is specific and conditional, not a blanket endorsement. It covers a particular drug, made a particular way, for a particular indication, dose, and population, and it comes attached to an official label that spells out approved uses, warnings, and contraindications. Approval can be full or made faster and provisional for serious diseases with few options, and it can be amended, restricted, or revoked as new information arrives.

Approval is a judgment made with incomplete knowledge at a single point in time. It rests on trials in selected patients and can never rule out every rare or long-term risk, which is why post-marketing surveillance continues afterward. An approved drug is one judged worth using under defined conditions, not one proven perfectly safe.